Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...
में बचाया:
मुख्य लेखकों: | , , , , , , , , |
---|---|
स्वरूप: | लेख |
भाषा: | अंग्रेज़ी |
प्रकाशित: |
Philipps-Universität Marburg
2023
|
विषय: | |
ऑनलाइन पहुंच: | पीडीएफ पूर्ण पाठ |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
इंटरनेट
पीडीएफ पूर्ण पाठबोधानक: |
urn:nbn:de:hebis:04-es2023-00054 |
---|---|
प्रकाशन तिथि: |
2023-03-06 |
स्रोत: |
Erstveröffentlichung: Kupke, A.; Volz, A.; Dietzel, E.; Freudenstein, A.; Schmidt, J.; Shams-Eldin, H.; Jany, S.; Sauerhering, L.; Krähling, V.; Gellhorn Serra, M.; et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 2022, 10, 533. https://doi.org/10.3390/vaccines10040533 |
Downloads: |
23 (2024), 32 (2023) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
यूआरएल में प्रवेश करें: |
https://archiv.ub.uni-marburg.de/es/2023/0005 https://doi.org/10.3390/vaccines10040533 |